Skip to content

Oncological and Functional Result of AbdominoPerineal Extra Levator Resection for Distal Rectal Cancer

A Registry Based Study of Clinical Results and of Health and Wellbeing in Patients After Abdominoperineal Resection for Rectal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01296984
Acronym
APER
Enrollment
1319
Registered
2011-02-16
Start date
2011-02-28
Completion date
2014-06-30
Last updated
2014-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

Rectal cancer, APR

Brief summary

The aim of the project is to evaluate the oncological and functional outcome of the more extensive perineal dissection - i.e the extra levator resection - in abdominoperineal resections in patients with rectal cancer. Hypothesis: Extra levator perineal resection reduces local recurrence three year postoperatively compared to traditional abdominoperineal resection and improves QoL 2-4 years postoperatively.

Detailed description

Low rectal cancer treated surgically by abdominoperineal resection (APR) has worse outcome than other rectal cancers operated with low anterior resection. In order to improve the outcome in the APR group a more extensive surgical procedure - the extra levator APR - has been suggested. This study aims to investigate both the oncological and the functional outcome of this method as compared to the traditional APR. Method: All Swedish patients undergoing abdominoperineal resection for rectal cancer 2007-2009 will be analysed regarding operative technique (traditional or extra levator resection). Data on all patients regarding pre op TNM classification, pathological report and local recurrence will be collected from the Swedish Rectal Cancer registry. A validated QoL form will be sent to each patient to further investigate the functional outcome, health economy and Quality of Life 2-4 years postoperatively. Data will be analysed regarding 3 year recurrence rate (primary endpoint) as well as functional result and QoL (secondary endpoints) in the two different groups - i.e traditional and extra levator APR.

Interventions

None listed

Sponsors

Swedish Cancer Foundation
CollaboratorOTHER
Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Rectal cancer operated with APR 2007-2009

Exclusion criteria

* No informed consent

Design outcomes

Primary

MeasureTime frameDescription
3-year local recurrence3 years postoperativelyLocal recurrence of rectal cancer 3 years after APR

Secondary

MeasureTime frameDescription
Reoperation, readmittance and mortality12 monthsRe-operation/s, length of hospital stay/s, re-admittance/s, mortality all within 12 months of primary surgery
Late morbidity24-48 months postoperativelyLate morbidity and functional disorders: prolonged wound healing, late infections, limping, pain, sitting problems, urinary incontinence, erectile dysfunction, stoma related dysfunction
Postoperative complications30 dayspostoperative morbidity: wound infection, deep infections, other infections, wound necrosis, pain, pneumonia, thrombosis
Health economy24-48 months postoperativelyHealth economy analysis of resource consumption
Stoma function24-36 months postopAssessment of stoma function related both to construction and surgical technique and patient position
Quality of Life24-48 months postoperativelyPatient experienced health and QoL 24-48 months postoperatively

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026